- Bullish trend confirmed on both short and long timeframes
- Consistently positive technical signals over the last month
- RSI at 34 — potential oversold entry point
Tema Oncology Etf ETF upgraded to Buy Candidate
(Updated on Jun 03, 2026)
The Tema Oncology Etf ETF price gained 0.0778% on the last trading day (Wednesday, 3rd Jun 2026), rising from $36.37 to $36.39. During the last trading day the ETF fluctuated 0.579% from a day low at $36.27 to a day high of $36.48. The price has been going up and down for this period, and there has been a -0.93% loss for the last 2 weeks. Volume fell on the last day by -15 thousand shares and in total, 43 thousand shares were bought and sold for approximately $1.57 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $36.09 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the ETF is expected to rise 4.12% during the next 3 months and, with a 90% probability hold a price between $37.57 and $42.31 at the end of this 3-month period.
CANC Signals & Forecast
The Tema Oncology Etf ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $37.51 and $37.89. A break-up above any of these levels will issue buy signals. Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 0.0778%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely.
Support, Risk & Stop-loss for Tema Oncology Etf ETF
Tema Oncology Etf finds support from accumulated volume at $36.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the ETF tends to have very controlled movements and with good liquidity the risk is considered very low in this ETF. During the last day, the ETF moved $0.210 between high and low, or 0.579%. For the last week the ETF has had daily average volatility of 1.39%.
Our recommended stop-loss: $34.29 (-5.79%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)
Trading Expectations (CANC) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Tema Oncology Etf to open at $36.38, and during the day (based on 14 day Average True Range), to move between $36.03 and $36.76, which gives a possible trading interval of +/-$0.722 (+/-2.00%) up or down from last closing price. If Tema Oncology Etf takes out the full calculated possible swing range there will be an estimated 2.00% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $36.37 (0.08%) than the resistance at $36.70 (0.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tema Oncology Etf ETF A Buy?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Sell to a Buy candidate.
Current score:
1.637
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $36.38 ( 0.0357%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CANC Performance
Trading levels for CANC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 36.59 | 0.541% |
| R2 | 36.51 | 0.321% |
| R1 | 36.46 | 0.185% |
| Price | 36.39 | |
| S1 | 36.30 | -0.256% |
| S2 | 36.25 | -0.392% |
| S3 | 36.17 | -0.613% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 39.72 | 9.14% |
| R2 | 37.16 | 2.09% |
| R1 | 36.70 | 0.83% |
| Price | 36.39 | |
| S1 | 36.37 | -0.0778% |
| S2 | 36.33 | -0.174% |
| S3 | 35.14 | -3.46% |
CANC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 10, 2025 | Dec 10, 2025 | Dec 11, 2025 | $0.0196 | 0.0567% |
| 2 | Dec 10, 2024 | Dec 11, 2024 | Dec 12, 2024 | $0.728 | 2.85% |
| 3 | Dec 12, 2023 | Dec 13, 2023 | Dec 15, 2023 | $0.149 | 0.586% |
FAQ
Click here for our free guide on how to buy Tema Oncology Etf ETF.
Buy CANC